Acute generalized exanthematous pustulosis due to benznidazole
- 1 November 2014
- journal article
- Published by Elsevier BV in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 2 (6), 800-802
- https://doi.org/10.1016/j.jaip.2014.08.003
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Nitroheterocyclic compounds are more efficacious than CYP51 inhibitors against Trypanosoma cruzi: implications for Chagas disease drug discovery and developmentScientific Reports, 2014
- Risk factors for acute generalized exanthematous pustulosis (AGEP)—results of a multinational case–control study (EuroSCAR)British Journal of Dermatology, 2007
- Mode of action of natural and synthetic drugs against Trypanosoma cruzi and their interaction with the mammalian hostComparative Biochemistry and Physiology Part A: Molecular & Integrative Physiology, 2007
- Acute generalized exanthematous pustulosis following a spider bite: Report of 3 casesJournal of the American Academy of Dermatology, 2006
- Cross-Comparison of Patch Test and Lymphocyte Proliferation Responses in Patients With a History of Acute Generalized Exanthematous PustulosisThe American Journal of Dermatopathology, 2005
- Acute Generalized Exanthematous Pustulosis in a Six-Year-Old BoyThe Journal of Dermatology, 2004
- T-cell involvement in drug-induced acute generalized exanthematous pustulosisJCI Insight, 2001
- Acute generalized exanthematous pustulosis (AGEP) – A clinical reaction patternJournal of Cutaneous Pathology, 2001